Skip to main content

Table 2 Loss of tumorigenicity of Li-7 cells according to passage times

From: Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib

Culture period Tumorigenicity
1 week (containing CD13+/CD166-) 4/4
4 weeks (CD13-/CD166- and CD13-/CD166+) 1/4
8 weeks (only CD13-/CD166+) 0/4*
  1. *p = 0.01.